Evidence map›Paper›PMID 42464148›Full record

ArticleBMC geriatrics2026

Lifelong cognitive reserve as a resilience factor for frailty progression and recovery in later life.

Meng Zhao, Shin J Liau, Xiangyun Ma, Chenkai Wu, Peining Liu, Sijing Peng, Si Chen, Ming Li, Kefang Wang, Yafei Si

Abstract read
In one paragraph

Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meng ZhaoSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.ORCID 0000-0002-2813-1112
Shin J LiauCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
Xiangyun MaSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Chenkai WuDuke Kunshan University, Kunshan, Jiangsu, China.
Peining LiuSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Sijing PengSchool of Nursing, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China.
Si ChenSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Ming LiSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. liming74@sdu.edu.cn.
Kefang WangSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. wangkf@sdu.edu.cn.
Yafei SiCentre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia.

Funding

Humanities and Social Science Department of the Ministry of Education Planning Fund 23YJCZH314National Natural Science Foundation of China 82404388Natural Science Foundation of Shandong Province ZR2024MG038
6 · The paper itself

Abstract

backgroundThe cognitive reserve reflects the cumulative cognitive enrichment across the life course and has been linked to resilience against cognitive decline and dementia. However, its role in shaping the dynamic course of physical frailty, including both progression and recovery, remains insufficiently understood. We aimed to examine the associations between lifelong composite cognitive reserve and transitions across frailty states and mortality among older adults in China.

methodsA longitudinal study was conducted using the data from 13,256 older adults from the Chinese Longitudinal Healthy Longevity Survey (mean age: 88.14 years; women: 59.00%; median follow-up duration: 6.00 years). A combined cognitive reserve Z-score was developed using early-life educational attainment, midlife occupational complexity, and late-life leisure activities. Frailty was operationalized using the FRAIL scale and reversion was measured by transitions from frailty at baseline to non-frailty during follow-up. Multi-state Markov models were performed to estimate the effects of the cognitive reserve on transitions among non-frail, pre-frail, frail, and death. Fine-Gray competing risks models were used to estimate the cognitive reserve associated with the risk of frailty and likelihood of reversion.

resultsA higher cognitive reserve was associated with lower hazards of progression from non-frail to pre-frail (HR = 0.95; 95% CI 0.92-0.98), pre-frail to frail (HR = 0.95; 95% CI 0.90-1.00), and from all frailty states to death (HR = 0.91-0.97). A greater cognitive reserve increased the likelihood of recovery from pre-frailty to non-frailty (HR = 1.07; 95% CI 1.03-1.10). Fine-Gray competing risks models showed that a higher cognitive reserve was associated with reduced risk of developing frailty (SHR = 0.97; 95% CI = 0.94-0.99) and increased likelihood of reversion (SHR = 1.28; 95% CI = 1.22-1.33).

conclusionsA higher cognitive reserve is linked to a decreased risk of developing frailty, slower progression, and a greater likelihood of improvement from pre-frailty to non-frailty, suggesting that lifelong cognitive enrichment enhances the physiological reserve beyond cognition. These findings suggest that interventions and policies that support the development of cognitive reserve across the life course may contribute to healthier frailty trajectories in later life.

Indexed as

Cognitive ReserveDisease ProgressionFrail ElderlyFrailtyRecovery of FunctionAgedAged, 80 and overChinaFemaleHumansLongitudinal StudiesMaleCognitive reserveFrailtyLongitudinal designMortalityResilienceReversion

Identifiers

PMID42464148
PMCPMC13656416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.